Thérapeutiques cibléesDELBALDO, Catherine; PIEDBOIS, Pascal.La Revue du praticien. Médecine générale. 2009, Num 823, pp 395-397, issn 0989-2737, 3 p.Article

Nouveaux médicaments dans le cancer bronchique : Les cancers Bronchiques = New drugs for bronchial cancer : Bronchial cancersDELBALDO, Catherine; FAIVRE, Sandrine; MONNERAT, Christian et al.La Presse médicale (1983). 2002, Vol 31, Num 17, pp 802-809, issn 0755-4982Article

PRISE EN CHARGE THÉRAPEUTIQUE DES CANCERS DES VOIES BILIAIRES ET DE LA VÉSICULE BILIAIRE = Management of biliary tract carcinomasDELBALDO, Catherine; LAURENT, Alexis; GRENIER, Julien et al.La Revue du praticien (Paris). 2009, Vol 59, Num 4, pp 469-473, issn 0035-2640, 5 p.Article

Les inhibiteurs de mTOR: Utilisation en cancérologieDREYER, Chantal; DELBALDO, Catherine; BOUATTOUR, Mohamed et al.Onko +. 2011, Vol 3, Num 20, pp 57-60, issn 2101-9495, 4 p.Article

Benefits of Adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: A meta-analysisDELBALDO, Catherine; MICHIELS, Stefan; SYZ, Nathalie et al.JAMA, the journal of the American Medical Association. 2004, Vol 292, Num 4, pp 470-484, issn 0098-7484, 15 p.Article

Combining Paclitaxel and Lapatinib as Second-line Treatment for Patients with Metastatic Transitional Cell Carcinoma: A Case SeriesCULINE, Stephane; SELLAM, Zineb; BOUAITA, Linda et al.Anticancer research. 2012, Vol 32, Num 9, pp 3949-3952, issn 0250-7005, 4 p.Article

Pharmacokinetic-pharmacodynamic relationships of imatinib and its main metabolite in patients with advanced gastrointestinal stromal tumorsDELBALDO, Catherine; CHATELUT, Etienne; RE, Micheline et al.Clinical cancer research. 2006, Vol 12, Num 20, pp 6073-6078, issn 1078-0432, 6 p., 1Article

Drug-induced epidermolysis bullosa acquisita with antibodies to type VII collagenDELBALDO, Catherine; MEI CHEN; FRIEDLI, André et al.Journal of the American Academy of Dermatology. 2002, Vol 46, Num 5, pp S161-S164, issn 0190-9622, SUPArticle

Population Pharmacokinetics and Pharmacogenetics of Imatinib in Children and AdultsRETAIN, Aurélie; KATTYGNARATH, Darouna; AZARD, Julie et al.Clinical cancer research (Print). 2008, Vol 14, Num 21, pp 7102-7109, issn 1078-0432, 8 p.Article

Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancerFAIVRE, Sandrine; DELBALDO, Catherine; ARMAND, Jean-Pierre et al.Journal of clinical oncology. 2006, Vol 24, Num 1, pp 25-35, issn 0732-183X, 11 p.Article

Phase i and pharmacokinetic study of aplidine, a new marine cyclodepsipeptide in patients with advanced malignanciesFAIVRE, Sandrine; CHLEZE, Stéphame; LOPEZ MARTIN, José Antonio et al.Journal of clinical oncology. 2005, Vol 23, Num 31, pp 7871-7880, issn 0732-183X, 10 p.Article

Enjeux et spécificités de l'évaluation radiologique des tumeurs neuroendocrines pancréatiques traitées par les thérapies ciblées : LES TUMEURS NEUROENDOCRINES DIGESTIVES = Specificities and challenges of imaging response in pancreatic neuroendocrine tumors treated with targeted therapiesDELBALDO, Catherine; RONOT, Maxime; DREYER, Chantal et al.Cancéro digest. 2012, Vol 4, Num 2, pp 93-97, issn 1953-5171, 5 p.Article

5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic AdenocarcinomaASSAF, Elias; VERLINDE-CARVALHO, Muriel; PAUL, Muriel et al.Oncology. 2011, Vol 80, Num 5-6, pp 301-306, issn 0030-2414, 6 p.Article

Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignanciesLE TOURNEAU, Christophe; FAIVRE, Sandrine; GIANELLA-BORRADORI, Athos et al.European journal of cancer (1990). 2010, Vol 46, Num 18, pp 3243-3250, issn 0959-8049, 8 p.Article

Pharmacokinetic profile of cetuximab (Erbitux) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinomaDELBALDO, Catherine; PIERGA, Jean-Yves; RAYMOND, Eric et al.European journal of cancer (1990). 2005, Vol 41, Num 12, pp 1739-1745, issn 0959-8049, 7 p.Article

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerCONROY, Thierry; DESSEIGNE, Françoise; BENNOUNA, Jaafar et al.The New England journal of medicine. 2011, Vol 364, Num 19, pp 1817-1825, issn 0028-4793, 9 p.Article

Safety of repeated administrations of ixabepilone given as a 3-hour infusion every other week in combination with irinotecan in patients with advanced malignanciesFAIVRE, Sandrine; DELBALDO, Catherine; BOIGE, Valérie et al.European journal of cancer (1990). 2008, Vol 44, Num 5, pp 674-682, issn 0959-8049, 9 p.Article

Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non-small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapyVANSTEENKISTE, Johan; LARA, Primo N; PECK, Ronald et al.Journal of clinical oncology. 2007, Vol 25, Num 23, pp 3448-3455, issn 0732-183X, 8 p.Article

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year : The french sarcoma groupBLAY, Jean-Yves; LE CESNE, Axel; CUPISSOL, Didier et al.Journal of clinical oncology. 2007, Vol 25, Num 9, pp 1107-1113, issn 0732-183X, 7 p.Article

Stents for palliation of obstructive metastatic colon cancer : Impact on management and chemotherapy administrationKAROUI, Mehdi; CHARACHON, Antoine; CHERQUI, Daniel et al.Archives of surgery (Chicago, IL. 1960). 2007, Vol 142, Num 7, pp 619-623, issn 0004-0010, 5 p.Article